[1] Harris E E R, Small W. Breast cancer screening in average-risk women:towards personalized screening[J]. British Journal of Radiology, 2019, 92(1103):20190660. [2] 陈俊, 丁炎, 吴鹏西, 等. 乳腺癌超声及超声造影特征与ER、PR、HER2及Ki-67的相关性[J]. 现代仪器与医疗, 2017, 23(1):8-10. [3] Alfano C M, Peng J, Andridge R R, et al. Inflammatory cytokines and comorbidity development in breast cancer survivors versus noncancer controls:evidence for accelerated aging[J]. Journal of Clinical Oncology, 2017, 35(2):149-156. [4] Wen D, Wen X, Yang Y, et al. Urban rural disparity in female breast cancer incidence rate in China and the increasing trend in parallel with socioeconomic development and urbanization in a rural setting[J]. Thoracic Cancer, 2018, 9(2):262-272. [5] 王乐华, 黄盱宁, 刘艳婷, 等. 超声造影在乳腺良恶性肿瘤鉴别诊断中的价值[J]. 实用临床医药杂志, 2017, 21(7):138-139, 142. [6] 张海丽, 刘小静, 庞慧燕. 非肿块型乳腺癌的超声表现与其病理特征的相关性研究[J]. 中国临床医学影像杂志, 2017, 28(9):617-619, 623. [7] Cai H, Li J, Gu B, et al. Extracts of Cordyceps sinensis inhibit breast cancer cell metastasis via down-regulation of metastasis-related cytokines expression[J]. Journal of Ethnopharmacology, 2018, 214(1):106-112. [8] 孙振, 周海红, 郭红云, 等. CARD9蛋白在乳腺癌组织中的表达及其临床意义[J]. 肿瘤, 2017, 37(3):245-254. [9] 史安臣, 王慕蓉, 杨洋, 等. 肿瘤细胞外泌体介导免疫逃逸的研究进展[J]. 中国肿瘤, 2019, 28(8):602-607. [10] 柴雨森, 王川江, 林时辉, 等. 白细胞介素-38的炎症免疫作用及调控机制研究进展[J]. 中国免疫学杂志, 2019, 35(2):230-235. [11] Liang J, Xu L, Zhou F, et al. MALAT1/miR-127-5p regulates osteopontin (OPN)-mediated proliferation of human chondrocytes through PI3K/Akt pathway[J]. Journal of Cellular Biochemistry, 2017, 119(1):431-439. [12] Walaszek K, Lower E E, Ziolkowski P, et al. Breast cancer risk in premalignant lesions:osteopontin splice variants indicate prognosis[J]. British Journal of Cancer, 2018, 119(10):1259-1266. [13] 许远兵, 甘星, 王志华. 骨桥蛋白和Stathmin-1表达在前列腺癌复发和生存预后评估中的应用研究[J]. 中国医师进修杂志, 2018, 41(7):642-645. |